Skip to main content
. 2022 Dec 1;37(4):625–635. doi: 10.1097/QAD.0000000000003437

Table 1.

Characteristics of the African Cohort Study women who received high-risk human papilloma virus genotyping (n = 1002).

Characteristic n (column %) High-risk HPV not detected [n (column %)] High-risk HPV detected [n (column %)] P value
Age (years) 0.329
 18–24 50 (5.0%) 19 (3.7%) 31 (6.3%)
 25–39 430 (42.9%) 221 (43.4%) 209 (42.4%)
 40–49 347 (34.6%) 178 (35.0%) 169 (34.3%)
 ≥50 175 (17.5%) 91 (17.9%) 84 (17.0%)
Site, country 0.143
 Kayunga, Uganda 98 (9.8%) 56 (11.0%) 42 (8.5%)
 South Rift Valley, Kenya 447 (44.6%) 237 (46.6%) 210 (42.6%)
 Kisumu West, Kenya 107 (10.7%) 58 (11.4%) 49 (9.9%)
 Mbeya, Tanzania 230 (22.9%) 103 (20.2%) 127 (25.8%)
 Abuja, Nigeria 62 (6.2%) 26 (5.1%) 36 (7.3%)
 Lagos, Nigeria 58 (5.8%) 29 (5.7%) 29 (5.9%)
Education 0.962
 No formal education 36 (3.6%) 19 (3.7%) 17 (3.4%)
 ≤Primary 256 (25.5%) 131 (25.7%) 125 (25.3%)
 ≥Secondary 710 (70.9%) 359 (70.5%) 351 (71.2%)
Age at 1st sexual intercourse 0.293
 ≤18 701 (71.0%) 349 (69.4%) 352 (72.6%)
 >18 287 (29.0%) 154 (30.6%) 133 (27.4%)
 Missing 14 6 8
Number of lifetime sexual partners 0.541
 No partner 323 (32.4%) 164 (32.3%) 159 (32.4%)
 One partner 595 (59.6%) 307 (60.6%) 288 (58.7%)
 Multiple (≥two) partners 80 (8.0%) 36 (7.1%) 44 (9.0%)
 Missing 4 2 2
HIV status 0.007
 Women living without HIV 134 (13.4%) 83 (16.3%) 51 (10.3%)
 Women living with HIV 868 (86.6%) 426 (83.7%) 442 (89.7%)
HIV-associated parameters (among WLWH only)
 On ART 0.010
 Yes 844 (97.3%) 420 (98.8%) 424 (95.9%)
 No 23 (2.7%) 5 (1.2%) 18 (4.1%)
 Missing 1 1 0
 CD4+ cell count (cells/μl) <0.001
 ≤200 57 (6.7%) 14 (3.4%) 43 (9.9%)
 201–500 311 (36.7%) 142 (34.2%) 169 (39.0%)
 >500 480 (56.6%) 259 (62.4%) 221 (51.0%)
 Missing 20 11 9
HIV viral load (copies/ml) 0.010
 ≤1000 772 (89.7%) 391 (92.4%) 381 (87.0%)
 >1000 89 (10.3%) 32 (7.6%) 57 (13.0%)
 Missing 7 3 4

P values were calculated using Pearson's chi-squared test. Statistically significant P values (P < 0.05) are in bold.